Grupo de investigación cardiovascular
GRINCAR
Universitat Autònoma de Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Universitat Autònoma de Barcelona (26)
2024
-
Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study
Cardiology Journal, Vol. 31, Núm. 1, pp. 103-110
-
Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study
Cardiovascular Diabetology, Vol. 23, Núm. 1
-
Repetitive ambulatory levosimendan as a bridge to heart transplantation
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry
Transplant International, Vol. 36
2022
-
Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study
Frontiers in Cardiovascular Medicine, Vol. 10
-
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
Frontiers in Cardiovascular Medicine, Vol. 9
-
Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry
Revista Espanola de Cardiologia, Vol. 75, Núm. 1, pp. 60-66
-
Utility of the IMPACT score for predicting heart transplant mortality. Analysis on a contemporary cohort of the Spanish Heart Transplant Registry
Clinical Transplantation, Vol. 36, Núm. 9
2021
-
Association of the kdigo risk classification with the prevalence of heart failure in patients with type 2 diabetes
Journal of Clinical Medicine, Vol. 10, Núm. 20
-
Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224
-
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Frontiers in Cardiovascular Medicine, Vol. 8
-
Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study
Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 337-344
2020
-
Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain
Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 361-367
-
Expert consensus statement on heart failure with reduced ejection fraction: beyond the guidelines
Revista Espanola de Cardiologia Suplementos, Vol. 20, Núm. SB, pp. 1-46
-
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure
REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164
2019
-
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure
Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314
2018
-
Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1081-1099
-
Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial
European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1128-1136